Nature-inspired metaheuristics for optimizing dose-finding and computationally challenging clinical trial designs
Clinical Trials · 2025
DOI: 10.1177/17407745251346396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials, 2025. Verfasst von Weng Kee Wong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of California, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Research Design, Maximum Tolerated Dose, Clinical Trials, Phase I as Topic, Clinical Trials, Phase II as Topic. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Division of Cancer Prevention, National Cancer Institute, Pennsylvania State University/ Pennsylvania Dept. of Health.
Abstract (Originalsprache)
Metaheuristics are commonly used in computer science and engineering to solve optimization problems, but their potential applications in clinical trial design have remained largely unexplored. This article provides a brief overview of metaheuristics and reviews their limited use in clinical trial settings. We focus on nature-inspired metaheuristics and apply one of its exemplary algorithms, the particle swarm optimization (PSO) algorithm, to find phase I/II designs that jointly consider toxicity and efficacy. As a specific application, we demonstrate the utility of PSO in designing optimal dose-finding studies to estimate the optimal biological dose (OBD) for a continuation-ratio model with four parameters under multiple constraints. Our design improves existing designs by protecting patients from receiving doses higher than the unknown maximum tolerated dose and ensuring that the OBD is estimated with high accuracy. In addition, we show the effectiveness of metaheuristics in addressing more computationally challenging design problems by extending Simon’s phase II designs to more than two stages and finding more flexible Bayesian optimal phase II designs with enhanced power.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, University of California, Los Angeles, CA, USA.
- Department of Pharmacy, Uppsala University, Uppsala, Sweden.
- Advanced Quantitative Sciences, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
- Department of Statistics, National Taipei University, New Taipei City.
- Department of Public Health Sciences, Pennsylvania State University, Hershey, PA, USA.
- Institute of Statistics and Data Science, National Tsing Hua University, Hsinchu.
ORCID-Profile: Weng Kee Wong
Förderung
- NCI NIH HHS
- Division of Cancer Prevention, National Cancer Institute
- Pennsylvania State University/ Pennsylvania Dept. of Health
- National Science and Technology Council, Mathematics Division of the National Center for Theoretical Scienes in Taiwan
- Ministry of Education, Taiwan
- National Taipei University
Zitieren
APA
Wong, W. K., Ryeznik, Y., Sverdlov, O., Chen, P. Y., Fang, X., Chen, R. B., Zhou, S., & Lee, J. J. (2025). Nature-inspired metaheuristics for optimizing dose-finding and computationally challenging clinical trial designs. Clinical Trials. https://doi.org/10.1177/17407745251346396
Vancouver
Wong WK, Ryeznik Y, Sverdlov O, Chen PY, Fang X, Chen RB, et al. Nature-inspired metaheuristics for optimizing dose-finding and computationally challenging clinical trial designs. Clinical Trials. 2025. doi:10.1177/17407745251346396
BibTeX
@article{Wong2025,
author = {Wong, Weng Kee and Ryeznik, Yevgen and Sverdlov, Oleksandr and Chen, Ping-Yang and Fang, Xinying and Chen, Ray-Bing and Zhou, Shouhao and Lee, J Jack},
title = {Nature-inspired metaheuristics for optimizing dose-finding and computationally challenging clinical trial designs},
journal = {Clinical Trials},
year = {2025},
doi = {10.1177/17407745251346396}
}
EUVIMED